Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Hummers

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Arthritis Care & Research|July 25, 2023
Differential Item Functioning on the Cochin Hand Function Scale Among People With Systemic Sclerosis by Language, Sex, and Disease Subtype: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort StudyMingyao Xu, Daphna Harel, Marie-Eve Carrier, et al.
ACR Open Rheumatology|March 11, 2025
Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic SclerosisBarbara White, Daniel E Furst, Tracy M Frech, et al.
BMC Pulmonary Medicine|April 30, 2024
Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trialMatthew R Lammi, Monica Mukherjee, Lesley Ann Saketkoo, et al.
Clinical Rheumatology|December 21, 2013
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosisMurray Baron, Lorinda Chung, Geneviève Gyger, et al.
Clinical and Experimental Rheumatology|July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationaleRobert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Plos One|May 1, 2012
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsChris Cheadle, Alan E Berger, Stephen C Mathai, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Arthritis Care & Research|July 25, 2023
Differential Item Functioning on the Cochin Hand Function Scale Among People With Systemic Sclerosis by Language, Sex, and Disease Subtype: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort StudyMingyao Xu, Daphna Harel, Marie-Eve Carrier, et al.
ACR Open Rheumatology|March 11, 2025
Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic SclerosisBarbara White, Daniel E Furst, Tracy M Frech, et al.
BMC Pulmonary Medicine|April 30, 2024
Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trialMatthew R Lammi, Monica Mukherjee, Lesley Ann Saketkoo, et al.
Clinical Rheumatology|December 21, 2013
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosisMurray Baron, Lorinda Chung, Geneviève Gyger, et al.
Clinical and Experimental Rheumatology|July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationaleRobert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Plos One|May 1, 2012
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsChris Cheadle, Alan E Berger, Stephen C Mathai, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Pageof 3